Thesan Pharmaceuticals Secures $49,000,000 Series B Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=955fa135-0338-4294-9ac8-ff33ba62e8e1
Date
2/25/2014
Company Name
Thesan Pharmaceuticals
Mailing Address
392 Camino de Estrella San Clemente, CA 92672
Company Description
Thesan Pharmaceuticals, Inc. is a preclinical biopharmaceutical company dedicated to the development of novel therapeutics for disorders of the skin. Thesan is focused on the discovery and development of New Chemical Entities that have the potential to provide significantly improved treatment options to patients.
Website
http://www.thesanpharma.com
Transaction Type
Venture Equity
Transaction Amount
$49,000,000
Transaction Round
Series B
Proceeds Purposes
We are very pleased with the deep financial backing provided by four top tier venture funds, which puts us in an unparalleled position as a biopharma to develop new drugs in this area.
M&A Terms
Venture Investor
Novo Ventures
Venture Investor
SV Life Sciences
Venture Investor
Lundbeckfond Ventures
Venture Investor
Novartis Venture Fund